391 related articles for article (PubMed ID: 10869260)
1. Physical activity prevents age-related impairment in nitric oxide availability in elderly athletes.
Taddei S; Galetta F; Virdis A; Ghiadoni L; Salvetti G; Franzoni F; Giusti C; Salvetti A
Circulation; 2000 Jun; 101(25):2896-901. PubMed ID: 10869260
[TBL] [Abstract][Full Text] [Related]
2. Restoration of nitric oxide availability after calcium antagonist treatment in essential hypertension.
Taddei S; Virdis A; Ghiadoni L; Magagna A; Favilla S; Pompella A; Salvetti A
Hypertension; 2001 Mar; 37(3):943-8. PubMed ID: 11244022
[TBL] [Abstract][Full Text] [Related]
3. Age-related reduction of NO availability and oxidative stress in humans.
Taddei S; Virdis A; Ghiadoni L; Salvetti G; Bernini G; Magagna A; Salvetti A
Hypertension; 2001 Aug; 38(2):274-9. PubMed ID: 11509489
[TBL] [Abstract][Full Text] [Related]
4. Vitamin C improves endothelium-dependent vasodilation by restoring nitric oxide activity in essential hypertension.
Taddei S; Virdis A; Ghiadoni L; Magagna A; Salvetti A
Circulation; 1998 Jun; 97(22):2222-9. PubMed ID: 9631871
[TBL] [Abstract][Full Text] [Related]
5. Vasodilation to bradykinin is mediated by an ouabain-sensitive pathway as a compensatory mechanism for impaired nitric oxide availability in essential hypertensive patients.
Taddei S; Ghiadoni L; Virdis A; Buralli S; Salvetti A
Circulation; 1999 Sep; 100(13):1400-5. PubMed ID: 10500040
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms responsible for endothelial dysfunction associated with acute estrogen deprivation in normotensive women.
Virdis A; Ghiadoni L; Pinto S; Lombardo M; Petraglia F; Gennazzani A; Buralli S; Taddei S; Salvetti A
Circulation; 2000 May; 101(19):2258-63. PubMed ID: 10811592
[TBL] [Abstract][Full Text] [Related]
7. Cyclooxygenase inhibition restores nitric oxide activity in essential hypertension.
Taddei S; Virdis A; Ghiadoni L; Magagna A; Salvetti A
Hypertension; 1997 Jan; 29(1 Pt 2):274-9. PubMed ID: 9039114
[TBL] [Abstract][Full Text] [Related]
8. Does lipoprotein(a) impair endothelial function?
Schlaich MP; John S; Langenfeld MR; Lackner KJ; Schmitz G; Schmieder RE
J Am Coll Cardiol; 1998 Feb; 31(2):359-65. PubMed ID: 9462580
[TBL] [Abstract][Full Text] [Related]
9. Identification of a cytochrome P450 2C9-derived endothelium-derived hyperpolarizing factor in essential hypertensive patients.
Taddei S; Versari D; Cipriano A; Ghiadoni L; Galetta F; Franzoni F; Magagna A; Virdis A; Salvetti A
J Am Coll Cardiol; 2006 Aug; 48(3):508-15. PubMed ID: 16875977
[TBL] [Abstract][Full Text] [Related]
10. Contribution of endothelium-derived nitric oxide to exercise-induced vasodilation.
Gilligan DM; Panza JA; Kilcoyne CM; Waclawiw MA; Casino PR; Quyyumi AA
Circulation; 1994 Dec; 90(6):2853-8. PubMed ID: 7994830
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms responsible for endothelial dysfunction induced by fasting hyperhomocystinemia in normotensive subjects and patients with essential hypertension.
Virdis A; Ghiadoni L; Cardinal H; Favilla S; Duranti P; Birindelli R; Magagna A; Bernini G; Salvetti G; Taddei S; Salvetti A
J Am Coll Cardiol; 2001 Oct; 38(4):1106-15. PubMed ID: 11583890
[TBL] [Abstract][Full Text] [Related]
12. Nitric oxide modulates tissue plasminogen activator release in normotensive subjects and hypertensive patients.
Giannarelli C; De Negri F; Virdis A; Ghiadoni L; Cipriano A; Magagna A; Taddei S; Salvetti A
Hypertension; 2007 Apr; 49(4):878-84. PubMed ID: 17339540
[TBL] [Abstract][Full Text] [Related]
13. Calcium antagonist treatment by lercanidipine prevents hyperpolarization in essential hypertension.
Taddei S; Virdis A; Ghiadoni L; Versari D; Salvetti G; Magagna A; Salvetti A
Hypertension; 2003 Apr; 41(4):950-5. PubMed ID: 12642509
[TBL] [Abstract][Full Text] [Related]
14. Impaired endothelium-dependent vasodilatation in subclinical hypothyroidism: beneficial effect of levothyroxine therapy.
Taddei S; Caraccio N; Virdis A; Dardano A; Versari D; Ghiadoni L; Salvetti A; Ferrannini E; Monzani F
J Clin Endocrinol Metab; 2003 Aug; 88(8):3731-7. PubMed ID: 12915662
[TBL] [Abstract][Full Text] [Related]
15. Effect of oral contraceptives on endothelial function in the peripheral microcirculation of healthy women.
Virdis A; Pinto S; Versari D; Salvetti G; Bernini G; Fruzzetti F; Genazzani AR; Taddei S; Salvetti A
J Hypertens; 2003 Dec; 21(12):2275-80. PubMed ID: 14654747
[TBL] [Abstract][Full Text] [Related]
16. beta-Adrenoceptor-mediated, nitric-oxide-dependent vasodilatation is abnormal in early hypertension: restoration by L-arginine.
Schlaich MP; Ahlers BA; Parnell MM; Kaye DM
J Hypertens; 2004 Oct; 22(10):1917-25. PubMed ID: 15361763
[TBL] [Abstract][Full Text] [Related]
17. Effect of insulin on acetylcholine-induced vasodilation in normotensive subjects and patients with essential hypertension.
Taddei S; Virdis A; Mattei P; Natali A; Ferrannini E; Salvetti A
Circulation; 1995 Nov; 92(10):2911-8. PubMed ID: 7586259
[TBL] [Abstract][Full Text] [Related]
18. Increased bioavailability of nitric oxide after lipid-lowering therapy in hypercholesterolemic patients: a randomized, placebo-controlled, double-blind study.
John S; Schlaich M; Langenfeld M; Weihprecht H; Schmitz G; Weidinger G; Schmieder RE
Circulation; 1998 Jul; 98(3):211-6. PubMed ID: 9697820
[TBL] [Abstract][Full Text] [Related]
19. The contribution of nitric oxide to exercise hyperemia in the human forearm.
Gordon MB; Jain R; Beckman JA; Creager MA
Vasc Med; 2002 Aug; 7(3):163-8. PubMed ID: 12553738
[TBL] [Abstract][Full Text] [Related]
20. Effect of calcium antagonist or beta blockade treatment on nitric oxide-dependent vasodilation and oxidative stress in essential hypertensive patients.
Taddei S; Virdis A; Ghiadoni L; Magagna A; Pasini AF; Garbin U; Cominacini L; Salvetti A
J Hypertens; 2001 Aug; 19(8):1379-86. PubMed ID: 11518845
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]